Difference between revisions of "Endostatin"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 50: | Line 50: | ||
| The binding to TG2 is cation dependent. | | The binding to TG2 is cation dependent. | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase interaction partners|*]] | [[Category:Tissue transglutaminase interaction partners|*]] |
Latest revision as of 12:15, 10 March 2015
Endostatin | |
---|---|
Substrate peptide name | Endostatin |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular matrix |
Swissprot ID | P39060 |
Interacting residues | R27, R139 |
Interacting sequence | |
TG2 Swissprot ID | P21980 |
Interacting residues of TG2 | Not determined yet |
Interacting sequence of TG2 | GTP binding site |
Structure | 1BNL |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:20156196 |
Notes | The binding to TG2 is cation dependent. |